# K173526: SENTIO MMG Gen 2

- Pathway: 510(k) (Traditional)
- Applicant: Medos International SARL
- Decided: Apr 5, 2018 after 142 days
- Product code: PDQ (Neurosurgical Nerve Locator)
- Device class: 2
- Regulation: 21 CFR 874.1820
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 13 generations back to K842956 (1984). 96 ancestors in all.
2 later devices descend from it; 1 cites it directly.
0 of 99 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K131304: Sentio MMG, Innovative Surgical Solutions, LLC ("Iss") (2014) Summary page 4.
- K162313: NuVasive Next Generation NVM5 System, Nu Vasive, Incorporated (2017) Summary page 4.
- K102084: Stimpod NMS450 Nerve Stimulator, Xavant Technology (Pty), Ltd. (2010) Summary page 4.

## Most influential descendants
- K243636: Neuralytix iD3 System (NTX-9001) (2025), 1 descendant of its own
- K260992: iD3 Nav Decompression Probe (NTX-9005); iD3 Ball Tip Stim Probe (NTX-9006); iD3 Nav Ball Tip Probe (NTX-9007) (2026), 0 descendants of its own

## Indications for use
This device is intended for use in surgical procedures to assist in locating and mapping motor nerves through the use of mechanomyographic (MMG) signals and electrical stimulus of nerves. The device provides information directly to the surgeon to help assess a patient's neurophysiologic status by measuring and comparing MMG signals throughout a surgical procedure.

Source page: https://510kreport.com/device/K173526
Methodology: https://510kreport.com/methodology